As of 2025-12-14, the Relative Valuation of Gemini Therapeutics Inc (GMTX) is (17.59) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.35 USD, the upside of Gemini Therapeutics Inc based on Relative Valuation is -1402.9%.
The range of the Relative Valuation is (17.42) - (18.11) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.1x - 16.8x | 16.4x |
| Forward P/E multiples | 15.4x - 16.8x | 16.1x |
| Fair Price | (17.42) - (18.11) | (17.59) |
| Upside | -1390.5% - -1441.7% | -1402.9% |
| Date | P/E |